CD274 and neoplasm: The β-blocker propranolol is particularly interesting, as it has been shown not only to upregulate PD-L1 expressed on tumor-associated macrophages (TAM), but also to enhance efficacy of an anti-CTLA4 therapy in soft tissue sarcoma [132].